Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • GOD (Garments of Destiny) Redefines Luxury Fashion with a Unique Blend of Astrology and Contemporary Design Business
  • WSCS India Registers Rapid Growth in Paper Cutlery Segment as Demand for Sustainable Packaging Rises Business
  • Educate Girls’ Team Balika leads the way towards a Sustainable World with its “Ek pedh Balika Shiksha ke liye” Initiative National
  • Ratul Puri on Net-Zero: Closing Skilling Gaps Could Unlock Millions of Green Jobs for India Business
  • Book Review of ‘The Waiting Lounge’ by Chet Kamal Parkash Lifestyle
  • KP Group is moving fast in the solar sector, receiving another large order of 12.50 MW CPP Business
  • AdtU holds HR Conclave 2.0 in Guwahati; experts endorse upskilling, flexible work arrangements, and diversity and inclusion in workplace Press Release
  • House of Armuse’s ethereal collection at the Fashion Connect Lifestyle

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Leo Tune Hearing Aids: Pioneering Affordable and Accessible Hearing Solutions Online Health
  • WS Audiology Strengthens Commitment to Innovation with New Research and Development Centre of Excellence in Hyderabad Health
  • A Healthy Heart: The Best Gift to Give Yourself this Holiday Season Health
  • MasMedi: Redefining Healthcare Solutions with Transparency, Accessibility and Customer-First Approach Health
  • Dr. A. K. Dwivedi’s Evidence-Based Work on Aplastic Anemia Gains National Recognition Health
  • Reinventing Success: Dr. Shama’s Revolutionary Impact on Mental Health Tech & Skill Enhancement Health

Recent Posts

  • Welcome Back To The Shadows: Noir Didn’t Return—We Just Finally Caught Up
  • SIXTY3 W.E. Bizpark: A New Landmark Powering Goregaon East’s Rise as Mumbai’s Next Business Hub
  • Aayush Wellness launches ‘Liver Detox Tablets’ to Capture Growing Demand in Preventive Wellness and Lifestyle Disease Management
  • Three Decades On, 10 Downing Street Remains a Constant in India’s Nightlife Evolution
  • Conclave on “IBC at Ten: Innovation, Reform and Emerging Challenges”

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Praveg’s Q3 FY26 Standalone Total Income Up 69.46 Percent and Consolidated Total Income up 65.29 Percent Business
  • Metadee Launches Viva Synth, India’s first generative AI for the edutech sector Technology
  • ET Excellence Award for Education Revolutionist Dr. Surya Chundi Business
  • Vantage Announces Launch of India’s First Chartered Global Investment Banking Certification Business
  • Celebrate With Style: A Curated Seasonal Style Edit 2026 For Festive Elegance and Timeless Gifting Lifestyle
  • Exide Empowers Future Engineers Business
  • IMS Proschool Strengthens Its Position as India’s 1st Destination for Accounting and Finance Courses Education
  • OTTplay launches 4 New International OTT platforms, Hallmark+, DUST, FUSE+ and Tastemade+ for the first time in India under OTTplay premium subscription Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme